Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for QA Oversight of IPC Activities – V 2.0

Posted on By

API Manufacturing: SOP for QA Oversight of IPC Activities – V 2.0

Standard Operating Procedure for QA Oversight of IPC Activities in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/120/2025
Supersedes SOP/API/120/2022
Page No. Page 1 of 9
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the role of Quality Assurance (QA) in the review, verification, and oversight of IPC (In-Process Control) activities carried out during API manufacturing to ensure all IPC operations are compliant with cGMP and internal quality standards.

2. Scope

This SOP applies to QA personnel responsible for monitoring IPC-related operations including sampling, data entry, IPC result verification,

equipment status verification, and sign-off on batch documents across all stages of API production.

3. Responsibilities

  • QA Officer: Perform real-time checks on IPC activities, review records, verify test results, and escalate any deviations or abnormalities.
  • QA Executive/Manager: Approve final IPC summaries, sign-off BMRs, and ensure adherence to established IPC specifications.
  • Production Chemist: Communicate with QA for each IPC stage and comply with verification requirements.
See also  API Manufacturing: SOP for Recrystallization for API Purification - V 2.0

4. Accountability

The Head – QA is accountable for ensuring that IPC oversight is conducted according to approved procedures and that all observations, reviews, and approvals are properly documented and traceable.

5. Procedure

5.1 QA Review of IPC Sampling

  1. QA shall verify that:
    • IPC samples are drawn as per SOP/API/081/2025
    • Correct containers and labeling are used
    • Sampling tools are clean and traceable
  2. Any deviation in sampling procedure shall be documented and reviewed for impact on product quality.

5.2 Verification of IPC Parameters

  1. QA shall verify that:
    • IPC results are within defined limits
    • Instrument calibration and status are valid
    • Entries in logbooks and BMRs are complete, signed, and dated
  2. Where IPC data is generated in QC (e.g., LOD, pH), QA shall cross-check raw data and test results with the reported values in BMR.
See also  API Manufacturing: SOP for Phase Separation Techniques - V 2.0

5.3 IPC Stage Sign-Off

  1. Before progressing to the next manufacturing stage:
    • QA shall verify the current IPC results
    • Approve stage-wise clearance in the BMR or IPC checklist
    • Ensure compliance with IPC hold times and frequencies

5.4 Observation of IPC Execution

  1. QA shall conduct random on-the-spot checks to verify:
    • Correct usage of SOPs and specifications
    • Equipment cleanliness and status tags
    • Personnel training and qualification
  2. QA shall document observations in the IPC Oversight Log (Annexure-1).

5.5 Documentation and Archival

  1. QA shall ensure:
    • All IPC records are legible, error-free, and traceable
    • Overwriting is properly justified and signed
    • Final IPC summary is approved before batch release
  2. QA shall archive the IPC Oversight Logs and associated records with the batch documentation for review during audits.

6. Abbreviations

  • IPC: In-Process Control
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • LOD: Loss on Drying
See also  API Manufacturing: SOP for Equipment Line Clearance Before Drying - V 2.0

7. Documents

  1. IPC Oversight Logbook (Annexure-1)
  2. Batch Manufacturing Record (BMR)
  3. IPC Summary Sheet

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211 – US FDA cGMP Guidelines
  • WHO TRS 986 – GMP for APIs

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: IPC Oversight Logbook

Date Batch No. Stage Observed IPC Parameter Observation QA Officer Remarks
13/04/2025 API-20250413 Drying LOD LOD out of spec, sample preserved Sunita Reddy Deviation initiated

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release GMP Requirement QA Head
13/04/2025 2.0 Added IPC stage clearance and checklist references Audit Observation QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Aerosol: SOP for Periodic Requalification of Utility Systems – V 2.0
Next Post: Creams: SOP for Stability Testing under Varying Humidity Conditions – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version